Dioclea violacea lectin modulates the gentamicin activity against multi-resistant strains and induces nefroprotection during antibiotic exposure.
Gentamicin is an aminoglycoside antibiotic used to treat infections of various origins. In the last few decades, the constant use of gentamicin has resulted in increased bacterial resistance and nephrotoxicity in some cases. In this study, we examined the ability of Dioclea violacea lectin (DVL) in modulate the antimicrobial activity of gentamicin and reduce the nephrotoxicity induced by this drug.
The minimum inhibitory concentration (MIC) obtained for DVL against all strains studied was not clinically relevant (MIC ≥ 1,024 μg/mL). However, when DVL was combined with gentamicin, a significant increase in antibiotic action was observed against Staphylococcus aureus and Escherichia coli. DVL also reduced antibiotic tolerance in S. aureus during 10 days of continuous treatment.
In addition, DVL presented a nephroprotective effect, reducing sodium excretion, N-Gal expression and urinary protein, that are important markers of glomerular and tubular injuries. Taken together, studies of inhibition of hemagglutinating activity, fluorescence spectroscopy and molecular docking revealed that gentamicin can interact with DVL via the carbohydrate recognition domain (CRD), suggesting that the results obtained in this study may be directly related to the interaction of DVL-gentamicin and with the ability of the lectin to interact with glycans present in the cells of the peritoneum.
Antioxidant, anti-inflammatory, and antiapoptotic effects of virgin coconut oil against antibiotic drug gentamicin-induced nephrotoxicity via the suppression of oxidative stress and modulation of iNOS/NF-ĸB/caspase-3 signaling pathway in Wistar rats.
Gentamicin is an effective antibiotic against severe infections; however, its major side effect is oxidative nephrotoxicity. We explored whether virgin coconut oil (VCO) could mitigate gentamicin-induced nephrotoxicity. Rats were fed with VCO-supplemented diet for 16 days against renal toxicity induced by gentamicin (100 mg/kg bw, ip) from Day 11 to 16. Gentamicin caused marked elevated serum urea, uric acid, and creatinine levels, followed by considerable depletion in renal antioxidant enzymes, glutathione (GSH), while the malondialdehyde (MDA) level increased significantly.
- It significantly increased renal cytokines and nitric oxide (NO) levels, confirmed by renal histopathology. The expression of inducible nitric oxide synthase (iNOS), nuclear factor-kappa B (NF-ĸB), and caspase-3 was prominently increased.
- VCO-supplemented diet significantly modulated the levels of biochemical indices, downregulated the expression of NO, iNOS, NF-ĸB, caspase-3, cytokines, and alleviated histopathological lesions. VCO protects against gentamicin-induced nephrotoxicity; thus, it could be a promising dietary supplement for patients undergoing gentamicin treatment.
- PRACTICAL APPLICATIONS: Gentamicin is an efficacious clinical antibiotic used against severe infections; however, the robust body of evidence indicates that the nephrotoxic side effect constrained its use. Virgin coconut oil (VCO) is an edible oil with growing human consumption and pharmacological effects.
- Our study has reported herein, for the first time, that VCO diet prevented the nephrotoxicity of gentamicin. Dietary supplementation of this oil could be beneficial in alleviating the nephrotoxic side effect of gentamicin in patients.

Cotinine-BSA Conjugate |
|||
COTN15-BSA | Alpha Diagnostics | 0.5 mg | EUR 343.2 |
Bovine Serum Albumin Biotinylated (Biotin-BSA) |
|||
BTN-BSA | Alpha Diagnostics | 5 mg | EUR 343.2 |
Ibrutinib drug-Bovine Serum Albumin (BSA) Conjugate |
|||
IBT15-BSA | Alpha Diagnostics | 100 ug | EUR 634.8 |
Dinitrophenyl (DNP)-BSA protein Conjugate |
|||
AV-9330-BSA | Alpha Diagnostics | 10 mg | EUR 343.2 |
mPEG-BSA (Molecular Weight: 5,000-linear) |
|||
PEG-BSA-05K | Alpha Diagnostics | 100 ug | EUR 343.2 |
mPEG-BSA (Molecular Weight: 10,000-linear) |
|||
PEG-BSA-10K | Alpha Diagnostics | 100 ug | EUR 343.2 |
mPEG-BSA (Molecular Weight: 20,000-linear) |
|||
PEG-BSA-20K | Alpha Diagnostics | 100 ug | EUR 343.2 |
mPEG-BSA (Molecular Weight: 40,000-linear) |
|||
PEG-BSA-40K | Alpha Diagnostics | 100 ug | EUR 343.2 |
Gentamicin [KLH] |
|||
DAG4484 | Creative Diagnostics | 1mg | EUR 1248 |
Gentamicin [HRP] |
|||
DAGA-032H | Creative Diagnostics | 1mg | EUR 1248 |
Gentamicin(GM) |
|||
AG022 | Unibiotest | 1 mg | EUR 627.6 |
Gentamicin-HRP |
|||
65-IG10 | Fitzgerald | 1 mg | EUR 716.4 |
Description: Conjugated Gentamicin-HRP hapten |
Gentamicin antibody |
|||
20-GG15 | Fitzgerald | 250 ul | EUR 220.8 |
Description: Goat polyclonal Gentamicin antibody |
Gentamicin antibody |
|||
20-GR15 | Fitzgerald | 250 ul | EUR 249.6 |
Description: Rabbit polyclonal Gentamicin antibody |
Gentamicin antibody |
|||
20C-CR1031S | Fitzgerald | 1 ml | EUR 262.8 |
Description: Sheep polyclonal Gentamicin antiserum |
Gentamicin antibody |
|||
10-1541 | Fitzgerald | 100 ug | EUR 470.4 |
Description: Mouse monoclonal Gentamicin antibody |
Gentamicin antibody |
|||
10-G02A | Fitzgerald | 500 ug | EUR 591.6 |
Description: Mouse monoclonal Gentamicin antibody |
Gentamicin Antibody |
|||
abx021011-200ug | Abbexa | 200 ug | EUR 393.6 |
Gentamicin Antibody |
|||
abx021012-1mg | Abbexa | 1 mg | EUR 1144.8 |
Gentamicin Antibody |
|||
abx021013-1mg | Abbexa | 1 mg | EUR 577.2 |
Gentamicin Antibody |
|||
20-abx210193 | Abbexa |
|
|
Gentamicin-OVA |
|||
80-1455 | Fitzgerald | 1 mg | EUR 781.2 |
Description: OVA conjugated Gentamicin Hapten |
Gentamicin-OVA |
|||
80-1456 | Fitzgerald | 1 mg | EUR 781.2 |
Description: OVA conjugated Gentamicin Hapten |
Gentamicin(GM) |
|||
AT022 | Unibiotest | 1mg | EUR 1134 |
Gentamicin sulfate |
|||
GA7939-10G | Glentham Life Sciences | 10 g | EUR 122.4 |
Gentamicin sulfate |
|||
GA7939-1G | Glentham Life Sciences | 1 g | EUR 55.2 |
Gentamicin sulfate |
|||
GA7939-25G | Glentham Life Sciences | 25 g | EUR 189.6 |
Gentamicin sulfate |
|||
GA7939-5G | Glentham Life Sciences | 5 g | EUR 93.6 |
Gentamicin (sulfate) |
|||
HY-A0276 | MedChemExpress | 500mg | EUR 142.8 |
Gentamicin sulfate |
|||
B1270-1G | Biovision | each | EUR 170.4 |
Gentamicin sulfate |
|||
B1270-25G | Biovision | each | EUR 1136.4 |
Gentamicin sulfate |
|||
B1270-5G | Biovision | each | EUR 405.6 |
(DRAAGQPAG)3 peptide (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) conjugated with BSA |
|||
DRAA31-BSA | Alpha Diagnostics | 0.5 mg | EUR 634.8 |
(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) conjugated with BSA |
|||
PPPP321-BSA | Alpha Diagnostics | 0.5 mg | EUR 634.8 |
(NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) conjugated with BSA |
|||
NVDP41-BSA | Alpha Diagnostics | 0.5 mg | EUR 634.8 |
(NANP)5 peptide (25-aa, repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) conjugated with BSA |
|||
NANP51-BSA | Alpha Diagnostics | 0.5 mg | EUR 634.8 |
Gentamicin Solution, Gentamicin Solution, 50 mg/mL |
|||
CCM1123-010 | Bio Basic | 10 mL | EUR 76.86 |
Bovine Serum Albumin (BSA) ELISA Kit |
|||
DLR-BSA-Ge-48T | DL Develop | 48T | EUR 464.4 |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Bovine Serum Albumin (BSA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine Serum Albumin (BSA) ELISA Kit |
|||
DLR-BSA-Ge-96T | DL Develop | 96T | EUR 592.8 |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Bovine Serum Albumin (BSA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine serum albumin (BSA) removal kit (Antibody based aff matrix; sufficient to remove 1-2 mg BSA from Bioprocessed material), 2 ml aff column |
|||
800-302-BSA | Alpha Diagnostics | 1 Kit | EUR 416.4 |
Bovine serum albumin (BSA) removal kit (Antibody based aff matrix; sufficient to remove 10-20 mg BSA from Bioprocessed material), 10 ml aff column |
|||
800-310-BSA | Alpha Diagnostics | 1 Kit | EUR 1074 |
Bovine serum albumin (BSA) removal kit (Antibody based aff matrix; sufficient to remove 25-50 mg BSA from Bioprocessed material), 25 ml aff column |
|||
800-325-BSA | Alpha Diagnostics | 1 Kit | EUR 1740 |
General Bovine Serum Albumin (BSA) ELISA Kit |
|||
RDR-BSA-Ge-48Tests | Reddot Biotech | 48 Tests | EUR 661.2 |
General Bovine Serum Albumin (BSA) ELISA Kit |
|||
RDR-BSA-Ge-96Tests | Reddot Biotech | 96 Tests | EUR 919.2 |
General Bovine Serum Albumin (BSA) ELISA Kit |
|||
RD-BSA-Ge-48Tests | Reddot Biotech | 48 Tests | EUR 632.4 |
General Bovine Serum Albumin (BSA) ELISA Kit |
|||
RD-BSA-Ge-96Tests | Reddot Biotech | 96 Tests | EUR 878.4 |
Gentamicin ELISA Kit |
|||
DEIA047 | Creative Diagnostics | 96T | EUR 1238.4 |
Description: This kit can be used in quantitative and qualitative analysis of gentamicin residue in vaccine and cell culture. |
Gentamicin, 50mg/ml |
|||
CA003-001 | GenDepot | 10ml | EUR 109.2 |
Gentamicin ELISA kit |
|||
55R-2233 | Fitzgerald | 1 kit | EUR 837.6 |
Description: Gentamicin ELISA kit for use in research laboratory |
Gentamicin monoclonal antibody |
|||
10R-11497 | Fitzgerald | 1 mg | EUR 1332 |
Description: Mouse anti- Gentamicin monoclonal antibody |
Gentamicin sulfate salt |
|||
20-abx082235 | Abbexa |
|
|
Gentamicin (GTM) Antibody |
|||
20-abx175177 | Abbexa |
|
|
Gentamicin Sulfate USP |
|||
G006-25G | TOKU-E | 25 g | EUR 470.4 |
Gentamicin Sulfate USP |
|||
G006-5G | TOKU-E | 5 g | EUR 199.2 |
Gentamicin Sulfate EP |
|||
G007-25G | TOKU-E | 25 g | EUR 478.8 |
Gentamicin Sulfate EP |
|||
G007-5G | TOKU-E | 5 g | EUR 219.6 |
Gentamicin ELISA Kit |
|||
K4206-100 | Biovision | each | EUR 1188 |
Vaccigel Alum adjuvant adsorbed with Bovine Serum Albumin (BSA @1 mg/ml), Vaccine adjuvant |
|||
AV-1010-BSA | Alpha Diagnostics | 1 ml | EUR 343.2 |
Pre-diluted BSA (bovine serum albumin) standards (1 set) for BCA Optima Protein Assay kit |
|||
BCA-BSA-1 | Alpha Diagnostics | 1 pk | EUR 196.8 |
Pre-diluted BSA (bovine serum albumin) standards (750 ug/ml) for BCA Optima Protein Assay kit |
|||
BCA-BSA-750 | Alpha Diagnostics | 1 ml | EUR 270 |
Gentamicin ELISA Kit (OKAO00127) |
|||||||||||||
OKAO00127 | Aviva Systems Biology | 96 Wells | EUR 638.4 | ||||||||||
Description: Description of target: Gentamicin is a complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity:
|
Gentamicin C1 pentaacetate salt |
|||
GA1270-10MG | Glentham Life Sciences | 10 mg | EUR 783.6 |
Gentamicin C1 pentaacetate salt |
|||
GA1270-1MG | Glentham Life Sciences | 1 mg | EUR 204 |
Gentamicin C2 pentaacetate salt |
|||
GA2476-5MG | Glentham Life Sciences | 5 mg | EUR 418.8 |
Gentamicin C1a pentaacetate salt |
|||
GA4559-10MG | Glentham Life Sciences | 10 mg | EUR 514.8 |
Gentamicin C1a pentaacetate salt |
|||
GA4559-25MG | Glentham Life Sciences | 25 mg | EUR 964.8 |
0.1g Gentamicin Sulfate Powder |
|||
61-098-RA | Scientific Laboratory Supplies | EACH | EUR 58.37 |
1g Gentamicin Sulfate Powder |
|||
61-098-RF | Scientific Laboratory Supplies | EACH | EUR 76.38 |
Sd Gentamicin Gm-10 |
|||
231299 | Scientific Laboratory Supplies | PK10 | EUR 50.86 |
BSA and BGG Stock standards (1 vial each @ 2 mg/ml) for BCA Optima Protein Assay kit |
|||
BSA-BGG-1 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Pre-diluted BSA (bovine serum albumin) standards (250, 125, 62.5, 31.25, and 0.0 ug/ml) for BCA Optima Protein Assay kit |
|||
BCA-BSA-2 | Alpha Diagnostics | 1 pk | EUR 196.8 |
Mouse Anti Gentamicin Monoclonal Antibody |
|||
DMABT-54913MG | Creative Diagnostics | 1 mg | EUR 920.4 |
Mouse Anti Gentamicin Monoclonal Antibody |
|||
DMABT-54914MG | Creative Diagnostics | 1 mg | EUR 920.4 |
Sheep Anti Gentamicin Polyclonal Antibody |
|||
DPBT-68266SG | Creative Diagnostics | 0.5 ml | EUR 920.4 |
Gentamicin C1 Sulfate EvoPure® |
|||
G031-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C1a sulfate EvoPure® |
|||
G032-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C2 sulfate EvoPure® |
|||
G033-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C2a sulfate EvoPure® |
|||
G034-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.
To investigate the relationship between MIC and clinical outcome in a randomized controlled trial that compared gentamicin 240 mg plus azithromycin 1 g with ceftriaxone 500 mg plus azithromycin 1 g. MIC analysis was performed on Neisseria gonorrhoeae isolates from all participants who were culture positive before they received treatment.
Viable gonococcal cultures were available from 279 participants, of whom 145 received ceftriaxone/azithromycin and 134 received gentamicin/azithromycin. Four participants (6 isolates) and 14 participants (17 isolates) did not clear infection in the ceftriaxone/azithromycin and gentamicin/azithromycin arms, respectively. MICs were determined by Etest on GC agar base with 1% Vitox.
The geometric mean MICs of azithromycin, ceftriaxone and gentamicin were compared using logistic and linear regression according to treatment received and N. gonorrhoeae clearance.As the azithromycin MIC increased, gentamicin/azithromycin treatment was less effective than ceftriaxone/azithromycin at clearing N. gonorrhoeae.
There was a higher geometric mean MIC of azithromycin for isolates from participants who had received gentamicin/azithromycin and did not clear infection compared with those who did clear infection [ratio 1.95 (95% CI 1.28-2.97)], but the use of categorical MIC breakpoints did not accurately predict the treatment response.
The geometric mean MIC of azithromycin was higher in isolates from the pharynx compared with genital isolates.We found that categorical resistance to azithromycin or ceftriaxone in vitro, and higher gentamicin MICs in the absence of breakpoints, were poorly predictive of treatment failure.
Gentamicin sulfate |
|||
B1270-1G | Biovision | each | EUR 170.4 |
Gentamicin sulfate |
|||
B1270-25G | Biovision | each | EUR 1136.4 |
Gentamicin sulfate |
|||
B1270-5G | Biovision | each | EUR 405.6 |
Gentamicin Sulfate USP |
|||
G006-25G | TOKU-E | 25 g | EUR 470.4 |
Gentamicin Sulfate USP |
|||
G006-5G | TOKU-E | 5 g | EUR 199.2 |
Gentamicin Sulfate EP |
|||
G007-25G | TOKU-E | 25 g | EUR 478.8 |
Gentamicin Sulfate EP |
|||
G007-5G | TOKU-E | 5 g | EUR 219.6 |
Gentamicin C1 pentaacetate salt |
|||
GA1270-10MG | Glentham Life Sciences | 10 mg | EUR 783.6 |
Gentamicin C1 pentaacetate salt |
|||
GA1270-1MG | Glentham Life Sciences | 1 mg | EUR 204 |
Gentamicin C2 pentaacetate salt |
|||
GA2476-5MG | Glentham Life Sciences | 5 mg | EUR 418.8 |
Gentamicin C1a pentaacetate salt |
|||
GA4559-10MG | Glentham Life Sciences | 10 mg | EUR 514.8 |
Gentamicin C1a pentaacetate salt |
|||
GA4559-25MG | Glentham Life Sciences | 25 mg | EUR 964.8 |
0.1g Gentamicin Sulfate Powder |
|||
61-098-RA | Scientific Laboratory Supplies | EACH | EUR 58.37 |
1g Gentamicin Sulfate Powder |
|||
61-098-RF | Scientific Laboratory Supplies | EACH | EUR 76.38 |
Gentamicin C1 Sulfate EvoPure® |
|||
G031-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C1a sulfate EvoPure® |
|||
G032-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C2 sulfate EvoPure® |
|||
G033-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C2a sulfate EvoPure® |
|||
G034-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin A sulfate EvoPure® |
|||
G035-10MG | TOKU-E | 10 mg | EUR 456 |
Gentamicin X2 sulfate EvoPure® |
|||
G036-2.5MG | TOKU-E | 2.5 mg | EUR 36 |
Gentamicin X2 sulfate EvoPure® |
|||
G036-PleaseContactusforPricing | TOKU-E | Please Contact us for Pricing | EUR 36 |
Gentamicin C2b sulfate EvoPure® |
|||
G062-10MG | TOKU-E | 10 mg | EUR 615.6 |
10mL Gentamicin Sulfate Liquid 5 |
|||
30-005-CR | Scientific Laboratory Supplies | PK10 | EUR 523.26 |
CYT387 sulfate salt |
|||
A3339-10 | ApexBio | 10 mg | EUR 212.4 |
Description: CYT387 is an ATP-competitive small molecule JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM for JAK1 and JAK2, respectively. CYT387 is useful for treatment of myeloproliferative disorders and anti-cancer. |
CYT387 sulfate salt |
|||
A3339-200 | ApexBio | 200 mg | EUR 1131.6 |
Description: CYT387 is an ATP-competitive small molecule JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM for JAK1 and JAK2, respectively. CYT387 is useful for treatment of myeloproliferative disorders and anti-cancer. |
CYT387 sulfate salt |
|||
A3339-5 | ApexBio | 5 mg | EUR 170.4 |
Description: CYT387 is an ATP-competitive small molecule JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM for JAK1 and JAK2, respectively. CYT387 is useful for treatment of myeloproliferative disorders and anti-cancer. |
CYT387 sulfate salt |
|||
A3339-50 | ApexBio | 50 mg | EUR 477.6 |
Description: CYT387 is an ATP-competitive small molecule JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM for JAK1 and JAK2, respectively. CYT387 is useful for treatment of myeloproliferative disorders and anti-cancer. |
Streptomycin sulfate salt |
|||
20-abx082471 | Abbexa |
|
|
Streptomycin sulfate salt |
|||
20-abx082589 | Abbexa |
|
|
Netilmicin sulfate salt |
|||
GA1999-100MG | Glentham Life Sciences | 100 mg | EUR 74.4 |
Netilmicin sulfate salt |
|||
GA1999-1G | Glentham Life Sciences | 1 g | EUR 187.2 |
Netilmicin sulfate salt |
|||
GA1999-250MG | Glentham Life Sciences | 250 mg | EUR 103.2 |
Paromomycin sulfate salt |
|||
GA4947-1G | Glentham Life Sciences | 1 g | EUR 64.8 |
Paromomycin sulfate salt |
|||
GA4947-25G | Glentham Life Sciences | 25 g | EUR 274.8 |
Paromomycin sulfate salt |
|||
GA4947-5G | Glentham Life Sciences | 5 g | EUR 112.8 |
Streptomycin sulfate salt |
|||
GA7700-100G | Glentham Life Sciences | 100 g | EUR 93.6 |
Streptomycin sulfate salt |
|||
GA7700-25G | Glentham Life Sciences | 25 g | EUR 60 |
Streptomycin sulfate salt |
|||
GA7700-50G | Glentham Life Sciences | 50 g | EUR 74.4 |
Streptomycin sulfate salt |
|||
GA7700-5G | Glentham Life Sciences | 5 g | EUR 52.8 |
Ribostamycin sulfate salt |
|||
GA7826-1G | Glentham Life Sciences | 1 g | EUR 274.8 |
Ribostamycin sulfate salt |
|||
GA7826-250MG | Glentham Life Sciences | 250 mg | EUR 132 |
Sisomicin sulfate salt |
|||
GA7855-1G | Glentham Life Sciences | 1 g | EUR 170.4 |
Sisomicin sulfate salt |
|||
GA7855-250MG | Glentham Life Sciences | 250 mg | EUR 93.6 |
Sisomicin sulfate salt |
|||
GA7855-5G | Glentham Life Sciences | 5 g | EUR 409.2 |
Apramycin sulfate salt |
|||
GA8829-1G | Glentham Life Sciences | 1 g | EUR 60 |
Apramycin sulfate salt |
|||
GA8829-25G | Glentham Life Sciences | 25 g | EUR 141.6 |
Apramycin sulfate salt |
|||
GA8829-5G | Glentham Life Sciences | 5 g | EUR 74.4 |
Colistin sulfate salt |
|||
GA9867-100MG | Glentham Life Sciences | 100 mg | EUR 64.8 |
Colistin sulfate salt |
|||
GA9867-1G | Glentham Life Sciences | 1 g | EUR 132 |
Colistin sulfate salt |
|||
GA9867-500MG | Glentham Life Sciences | 500 mg | EUR 93.6 |
Colistin sulfate salt |
|||
GA9867-5G | Glentham Life Sciences | 5 g | EUR 370.8 |
Minoxidil sulfate salt |
|||
GP8215-100MG | Glentham Life Sciences | 100 mg | EUR 93.6 |
Minoxidil sulfate salt |
|||
GP8215-1G | Glentham Life Sciences | 1 g | EUR 163.2 |
Dodecyl sulfate sodium salt |
|||
abx185405-500g | Abbexa | 500 g | EUR 427.2 |
Dextran sulfate sodium salt |
|||
B8205-100000 | ApexBio | 100 g | EUR 616.8 |
Dextran sulfate sodium salt |
|||
B8205-500000 | ApexBio | 500 g | EUR 1730.4 |
Polymixin B sulfate salt |
|||
GA4910-10G | Glentham Life Sciences | 10 g | EUR 322.8 |
Polymixin B sulfate salt |
|||
GA4910-1G | Glentham Life Sciences | 1 g | EUR 103.2 |
Polymixin B sulfate salt |
|||
GA4910-5G | Glentham Life Sciences | 5 g | EUR 208.8 |
OCTYL SULFATE SODIUM SALT (SODIUM OCTYL SULFATE) |
|||
715001 | Survival Technologies | each | Ask for price |
Gentamicin Sulfate Solution (50 mg/mL in Water) |
|||
G046-20ML | TOKU-E | 20 mL | EUR 132 |
DHEA 3 Sulfate Sodium Salt |
|||
30-AD25 | Fitzgerald | 1 gram | EUR 412.8 |
Description: DHEA 3 Sulfate Sodium Salt |
Chondroitin sulfate A sodium salt |
|||
GC6763-100G | Glentham Life Sciences | 100 g | EUR 237.6 |
Chondroitin sulfate A sodium salt |
|||
GC6763-10G | Glentham Life Sciences | 10 g | EUR 69.6 |
Chondroitin sulfate A sodium salt |
|||
GC6763-25G | Glentham Life Sciences | 25 g | EUR 102 |
Chondroitin sulfate A sodium salt |
|||
GC6763-50G | Glentham Life Sciences | 50 g | EUR 151.2 |
Chondroitin sulfate A sodium salt |
|||
GC6763-5G | Glentham Life Sciences | 5 g | EUR 60 |
Dextran Sulfate Sodium Salt, MW 8,000 |
|||
D0800-025 | GenDepot | 25g | EUR 278.4 |
Dextran Sulfate Sodium Salt, MW 8,000 |
|||
D0800-100 | GenDepot | 100g | EUR 619.2 |
Dextran Sulfate Sodium Salt, MW 8,000 |
|||
D0800-101 | GenDepot | 1Kg | EUR 3705.6 |
Dextran Sulfate Sodium Salt, MW 500,000 |
|||
D0811-010 | GenDepot | 10g | EUR 198 |
Dextran Sulfate Sodium Salt, MW 500,000 |
|||
D0811-050 | GenDepot | 50g | EUR 273.6 |
Dextran Sulfate Sodium Salt, MW 500,000 |
|||
D0811-100 | GenDepot | 100g | EUR 400.8 |
Dextran Sulfate Sodium Salt, MW 500,000 |
|||
D0811-101 | GenDepot | 1Kg | EUR 3057.6 |
Ethyl sulfate, sodium salt, 10 mg |
|||
0902-10 | AthenaES | 10 mg | EUR 158.4 |
Ethyl sulfate, sodium salt, 2 mg |
|||
0902-2 | AthenaES | 2 mg | EUR 82.8 |
D-Glucosamine sulfate, potassium chloride salt |
|||
GC1036-100G | Glentham Life Sciences | 100 g | EUR 103.2 |